CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis [Phase 1, Phase 2]

A phase 1/2 trial investigating hematopoietic stem cell support in patients with refractory sarcoidosis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Northwestern University | Conditions: Sarcoidosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-02-24